Real-time enrollment status for this sleep disturbances in smith-magenis syndrome clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 8:18 PM UTC
| NCT Number | NCT03154697 |
| Recruiting Status | Recruiting |
| Condition | Sleep Disturbances in Smith-Magenis Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 1,000 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vanda Pharmaceuticals |
| Last Updated on CT.gov | March 20, 2024 (Mar 20, 2024) |
As of July 18, 2026: Clinical trial NCT03154697 is currently recruiting participants. This clinical trial study for sleep disturbances in smith-magenis syndrome is actively seeking new participants at 1 location across the United States. The study is sponsored by Vanda Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03154697 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03154697 was last updated Mar 20, 2024 (March 20, 2024). HelloStudys verifies this status automatically.